WO2021100640A1 - 改変シアノバクテリア、改変シアノバクテリアの製造方法、及び、タンパク質の製造方法 - Google Patents

改変シアノバクテリア、改変シアノバクテリアの製造方法、及び、タンパク質の製造方法 Download PDF

Info

Publication number
WO2021100640A1
WO2021100640A1 PCT/JP2020/042549 JP2020042549W WO2021100640A1 WO 2021100640 A1 WO2021100640 A1 WO 2021100640A1 JP 2020042549 W JP2020042549 W JP 2020042549W WO 2021100640 A1 WO2021100640 A1 WO 2021100640A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
outer membrane
cell wall
cyanobacteria
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2020/042549
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
征司 児島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panasonic Intellectual Property Management Co Ltd
Original Assignee
Panasonic Intellectual Property Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panasonic Intellectual Property Management Co Ltd filed Critical Panasonic Intellectual Property Management Co Ltd
Priority to EP20890876.4A priority Critical patent/EP4063483A4/en
Priority to CN202080078397.XA priority patent/CN114651060A/zh
Priority to JP2021558356A priority patent/JP7766262B2/ja
Publication of WO2021100640A1 publication Critical patent/WO2021100640A1/ja
Priority to US17/748,617 priority patent/US20220325312A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/101—Plasmid DNA for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/80—Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Definitions

  • the present disclosure relates to modified cyanobacteria having improved secretory productivity of proteins that secrete proteins produced in the cells to the outside of the cells, methods for producing modified cyanobacteria, and methods for producing proteins.
  • a substance production method that does not depend on fossil fuels and has a low environmental load is required in a wide range of industrial fields from the chemical industry to the agriculture, fishery and livestock industry.
  • a production system that meets the above requirements because substance production using microorganisms can be performed in an environment of normal temperature and pressure, and a wide range of compound species can be produced with the development of genetic engineering technology in recent years. It is attracting attention as.
  • photosynthetic microorganisms such as cyanobacteria and algae can use carbon dioxide (CO 2 ) in the air as a raw material by using light as an energy source, and therefore, they are particularly expected as a carbon-neutral next-generation substance production system. ing.
  • Non-Patent Document 1 As substances produced using cyanobacteria, ethanol (Non-Patent Document 1), isobutanol (Non-Patent Document 2), alkans (Patent Document 2), fatty acids (Patent Document 1), and proteins (Non-Patent Document 1). Patent Document 3) and the like have been reported.
  • Non-Patent Document 4 discloses a method for expressing a protein in cyanobacteria.
  • the present disclosure provides a modified cyanobacteria having improved secretory productivity of a protein, a method for producing a modified cyanobacteria, and a method for producing a protein using the modified cyanobacteria.
  • the function of the protein involved in the binding between the outer membrane and the cell wall is suppressed or lost in the cyanobacteria.
  • modified cyanobacteria of the present disclosure and the method for producing modified cyanobacteria, it is possible to provide modified cyanobacteria having improved protein secretion productivity. Further, according to the method for producing a protein of the present disclosure, a protein can be efficiently produced.
  • FIG. 1 is a diagram schematically showing the cell surface layer of cyanobacteria.
  • FIG. 2 is a transmission electron microscope observation image of an ultrathin section of the modified cyanobacteria of Example 1.
  • FIG. 3 is an enlarged image of the broken line region A of FIG.
  • FIG. 4 is a transmission electron microscope image of an ultrathin section of the modified cyanobacteria of Example 2.
  • FIG. 5 is an enlarged image of the broken line region B of FIG.
  • FIG. 6 is a transmission electron microscope image of an ultrathin section of the modified cyanobacteria of Comparative Example 1.
  • FIG. 7 is an enlarged view of the broken line region C of FIG.
  • Cyanobacteria also called blue-green bacteria or blue-green algae
  • Cyanobacteria are a group of eubacteria that decompose water by photosynthesis to produce oxygen and fix CO 2 in the air with the obtained energy. Cyanobacteria can also fix nitrogen (N 2 ) in the air depending on the species.
  • N 2 nitrogen
  • cyanobacteria grow quickly and have high light utilization efficiency, and in addition, genetic manipulation is easier than other algae species. Therefore, regarding the utilization of cyanobacteria among photosynthetic microorganisms. Active research and development is taking place.
  • Non-Patent Document 1 examples of substance production using cyanobacteria include ethanol (Non-Patent Document 1), isobutanol (Non-Patent Document 2), alcans (Patent Document 2), fatty acids (Patent Document 1), and the like. Fuel production has been reported.
  • Non-Patent Document 3 describes a method for producing a protein using the cyanobacteria Synechocystis sp. PCC6803 strain.
  • the document discloses a promoter base sequence for activating transcription of an ethylene synthase gene with high efficiency and a ribosome binding sequence for enhancing translation.
  • Non-Patent Document 4 discloses a method of inserting a gene encoding a protein into the NS-pCC2 region on a plasmid carried by this strain when expressing a recombinant protein using the Synechocsis sp. PCC6803 strain as a host. ing. It has been reported that by using this method, the expression efficiency of the recombinant protein is improved about 14 times as compared with the case where the gene is inserted on the chromosomal DNA (deoxyribonucleic acid).
  • the present inventor has found that by partially removing the outer membrane covering the cell wall of cyanobacteria from the cell wall, proteins produced in the cells of cyanobacteria are easily secreted outside the cells. It was. As a result, the protein secreted outside the bacterial cells can be efficiently recovered without disrupting the bacterial cells of cyanobacteria. In addition, since cyanobacteria can be continuously used even after the protein is recovered, the production efficiency is improved.
  • the present disclosure it is possible to provide a modified cyanobacteria having improved protein secretion productivity. Further, by culturing the modified cyanobacteria of the present disclosure, a protein can be efficiently produced.
  • the function of the protein involved in the binding between the outer membrane and the cell wall is suppressed or lost in the cyanobacteria.
  • the modified cyanobacteria As a result, in the modified cyanobacteria, the binding between the cell wall and the outer membrane (for example, the amount of binding and the binding force) is partially reduced, so that the outer membrane is easily partially detached from the cell wall. Therefore, the protein produced in the cells easily leaks to the outside of the outer membrane, that is, to the outside of the cells. Therefore, according to the modified cyanobacteria according to one aspect of the present disclosure, it is possible to provide cyanobacteria having improved protein secretion productivity. Further, according to the modified cyanobacteria according to one aspect of the present disclosure, since it is not necessary to crush the cells to recover the protein, the modified cyanobacteria are repeatedly used to produce the protein even after the protein is recovered. be able to.
  • the proteins involved in the binding between the outer membrane and the cell wall are SLH (Surface Layer Homology) domain-retaining outer membrane protein and the cell wall-pyruvic acid modifying enzyme. There may be at least one.
  • the modified cyanobacteria for example, (i) an enzyme that catalyzes the reaction of modifying the SLH domain-retaining outer membrane protein that binds to the cell wall and the bound sugar chain on the surface of the cell wall with pyruvate (that is, cell wall-pyruvate modification). At least one function of the enzyme) is suppressed or lost, or the expression of (ii) SLH domain-retaining outer membrane protein and at least one cell wall-pyruvate modifying enzyme is suppressed. Therefore, the binding (that is, the binding amount and binding force) between the SLH domain of the SLH domain-retaining outer membrane protein in the outer membrane and the covalently bound sugar chain on the surface of the cell wall is reduced.
  • the outer membrane is easily detached from the cell wall at the portion where the bond between the outer membrane and the cell wall is weakened. Therefore, according to the modified cyanobacteria according to one aspect of the present disclosure, the binding between the outer membrane and the cell wall is reduced, so that the outer membrane is easily partially detached from the cell wall, so that the protein produced in the cells is produced. It becomes easy to leak out of the bacterial cells.
  • the SLH domain-retaining outer membrane protein is Slr1841 consisting of the amino acid sequence shown in SEQ ID NO: 1, NIES970_09470 consisting of the amino acid sequence shown in SEQ ID NO: 2, and SEQ ID NO: Anacy_3458 consisting of the amino acid sequence represented by 3 or a protein having an amino acid sequence 50% or more identical to that of any of these SLH domain-retaining outer membrane proteins may be used.
  • any SLH domain-retaining outer membrane protein shown in SEQ ID NOs: 1 to 3 above, or any of these SLH domain-retaining outer membrane proteins and an amino acid sequence can be obtained.
  • the function of proteins that are 50% or more identical is suppressed or lost, or
  • the expression of a protein having an amino acid sequence that is 50% or more identical to that of a retained outer membrane protein is suppressed.
  • the function of the SLH domain-retaining outer membrane protein in the outer membrane or the protein having the same function as the SLH domain-retaining outer membrane protein is suppressed or lost, or (ii).
  • the expression level of the SLH domain-retaining outer membrane protein or the protein having the same function as the SLH domain-retaining outer membrane protein in the outer membrane is reduced. Therefore, according to the modified cyanobacteria according to one aspect of the present disclosure, the binding amount and binding force of the binding domain (for example, SLH domain) for binding the outer membrane to the cell wall are reduced, so that the outer membrane has a binding force. It becomes easier to partially detach from the cell wall.
  • the cell wall-pyruvate modifying enzyme is Slr0688 consisting of the amino acid sequence shown in SEQ ID NO: 4, Synpcc7942_1529 consisting of the amino acid sequence shown in SEQ ID NO: 5, and SEQ ID NO: 6. It may be Anacy_1623 consisting of the amino acid sequence shown by, or a protein having an amino acid sequence of 50% or more identical to that of any of these cell wall-pyruvate modifying enzymes.
  • any cell wall-pyruvate modifying enzyme shown in SEQ ID NOs: 4 to 6 above or any one of these cell wall-pyruvate modifying enzymes and the amino acid sequence are 50%.
  • the function of the same protein is suppressed or lost, or
  • any cell wall-pyruvate modifying enzyme shown in SEQ ID NOs: 4 to 6 above or any of these cell wall-pyruvate modifications are suppressed.
  • the function of the cell wall-pyruvic acid modifying enzyme or a protein having the same function as the enzyme is suppressed or lost, or (ii) the cell wall-pyruvic acid modifying enzyme or the enzyme is used.
  • the expression level of proteins with equivalent functions is reduced. This makes it difficult for the covalently bound sugar chains on the surface of the cell wall to be modified with pyruvic acid, so that the amount and binding force of the sugar chains on the cell wall to bind to the SLH domain of the SLH domain-retaining outer membrane protein in the outer membrane. Is reduced.
  • the covalent sugar chain on the surface of the cell wall is less likely to be modified with pyruvic acid, the binding force between the cell wall and the outer membrane is weakened, and the outer membrane is released from the cell wall. It becomes easier to partially detach.
  • the gene expressing the protein involved in the binding between the outer membrane and the cell wall may be deleted or inactivated.
  • the modified cyanobacteria As a result, in the modified cyanobacteria, the expression of the protein involved in the binding between the cell wall and the outer membrane is suppressed, or the function of the protein is suppressed or lost, so that the binding between the cell wall and the outer membrane (so-called). , Bonding amount and binding force) are partially reduced. As a result, in the modified cyanobacteria, the outer membrane is easily detached from the cell wall, so that the protein produced in the cells is easily leaked to the outside of the outer membrane, that is, to the outside of the cells. Therefore, the modified cyanobacteria according to one aspect of the present disclosure improve the secretory productivity of proteins. Further, according to the modified cyanobacteria according to one aspect of the present disclosure, since it is not necessary to crush the cells to recover the protein, the modified cyanobacteria are repeatedly used to produce the protein even after the protein is recovered. be able to.
  • the genes expressing the protein involved in the binding between the outer membrane and the cell wall are the gene encoding the SLH domain-retaining outer membrane protein and the cell wall-pyruvate. It may be at least one of the genes encoding the modifying enzyme.
  • the modified cyanobacteria As a result, in the modified cyanobacteria, at least one gene encoding the SLH domain-retaining outer membrane protein and the gene encoding the cell wall-pyruvic acid modifying enzyme are deleted or inactivated. Therefore, in the modified cyanobacteria, for example, the expression of at least one of (i) SLH domain-retaining outer membrane protein and cell wall-pyruvate modifying enzyme is suppressed, or (ii) SLH domain-retaining outer membrane protein and cell wall. -At least one function of pyruvate modifying enzyme is suppressed or lost.
  • the binding that is, the binding amount and binding force
  • the binding between the outer membrane and the cell wall is reduced, so that the outer membrane is easily partially detached from the cell wall, so that the protein produced in the cells is produced. It becomes easy to leak out of the bacterial cells.
  • the gene encoding the SLH domain-retaining outer membrane protein comprises slr1841 consisting of the nucleotide sequence shown in SEQ ID NO: 7, and the nucleotide sequence represented by SEQ ID NO: 8. It may be nies970_09470, anacy_3458 consisting of the base sequence shown by SEQ ID NO: 9, or a gene whose base sequence is 50% or more identical to any of these genes.
  • the gene encoding any of the SLH domain-bearing outer membrane proteins shown in SEQ ID NOs: 7 to 9 above, or a gene that is 50% or more identical to the base sequence of any of these genes. Is deleted or inactivated. Therefore, in the modified cyanobacteria, (i) expression of any of the above SLH domain-retaining outer membrane proteins or a protein having a function equivalent to that of any of these proteins is suppressed, or (ii) the above. The function of any SLH domain-retaining outer membrane protein or a protein having a function equivalent to that of any of these proteins is suppressed or lost.
  • the binding amount and binding force of the binding domain for example, SLH domain
  • the binding domain for example, SLH domain
  • the gene encoding the cell wall-pyruvate modifying enzyme is slr0688 consisting of the base sequence shown by SEQ ID NO: 10 and synpcc7942_1529 consisting of the base sequence shown by SEQ ID NO: 11. , Anacy_1623 consisting of the base sequence shown by SEQ ID NO: 12, or a gene whose base sequence is 50% or more identical to any of these genes.
  • the nucleotide sequence of the gene encoding any cell wall-pyruvic acid modifying enzyme shown in SEQ ID NOs: 10 to 12 above or the gene encoding any of these enzymes is 50% or more identical.
  • the gene is deleted or inactivated. Therefore, in the modified cyanobacteria, (i) expression of any of the above cell wall-pyruvic acid modifying enzymes or a protein having a function equivalent to that of any of these enzymes is suppressed, or (ii) any of the above.
  • the function of the cell wall-pyruvic acid modifying enzyme or a protein having a function equivalent to that of any of these enzymes is suppressed or lost.
  • the covalently bound sugar chains on the surface of the cell wall to be modified with pyruvic acid, so that the amount and binding force of the sugar chains on the cell wall to bind to the SLH domain of the SLH domain-retaining outer membrane protein in the outer membrane. Is reduced. Therefore, in the modified cyanobacteria according to one aspect of the present disclosure, the amount of the sugar chain for binding the cell wall 4 to the outer membrane is reduced by pyruvic acid, so that the binding force between the cell wall and the outer membrane is weakened. The outer membrane is more likely to partially detach from the cell wall.
  • the method for producing modified cyanobacteria includes a step of suppressing or losing the function of a protein involved in the binding between the outer membrane and the cell wall in cyanobacteria.
  • modified cyanobacteria As a result, in the produced modified cyanobacteria, the binding between the cell wall and the outer membrane (so-called binding amount and binding force) is partially reduced, so that the outer membrane is easily partially detached from the cell wall. Therefore, in modified cyanobacteria, proteins produced in the cells are likely to leak out of the outer membrane (that is, out of the cells). Therefore, according to the method for producing modified cyanobacteria according to one aspect of the present disclosure, it is possible to provide cyanobacteria having improved protein secretion productivity. Further, in the produced modified cyanobacteria, the protein produced in the cells leaks out of the cells, so that it is not necessary to crush the cells in order to recover the protein. Therefore, according to the method for producing modified cyanobacteria according to one aspect of the present disclosure, it is possible to provide a highly efficient modified cyanobacteria that can be used repeatedly even if the protein is recovered.
  • the method for producing a protein according to one aspect of the present disclosure includes a step of culturing any of the above-mentioned modified cyanobacteria.
  • the protein leaked out of the cells of the modified cyanobacteria can be recovered, so that it is not necessary to recover the cells from the culture solution and crush the cells in order to recover the protein.
  • the protein can be recovered while culturing the modified cyanobacteria.
  • the modified cyanobacteria can be used repeatedly even after the protein is recovered, it is not necessary to prepare a new modified cyanobacteria each time the protein is produced. Therefore, according to the protein production method according to one aspect of the present disclosure, the protein can be efficiently produced.
  • each figure is not necessarily exactly illustrated.
  • substantially the same configuration is designated by the same reference numerals, and duplicate description may be omitted or simplified.
  • the numerical range does not only represent a strict meaning, but also includes measuring a substantially equivalent range, for example, the amount of protein (for example, number or concentration, etc.) or the range thereof.
  • both the bacterial cell and the cell represent one cyanobacterial individual.
  • the identity of the base sequence and the amino acid sequence is calculated by the BLAST (Basic Local Alignment Search Tool) algorithm. Specifically, it is calculated by performing pairwise analysis with the BLAST program available on the website of NCBI (National Center for Biotechnology Information) (https://blast.ncbi.nlm.nih.gov/Blast.cgi). To. Information on the cyanobacterial gene and the protein encoded by the gene is published, for example, in the NCBI database described above and Cyanobase (http://genome.microbedb.jp/cyanobase/). From these databases, the amino acid sequence of the protein of interest and the base sequence of the gene encoding those proteins can be obtained.
  • NCBI National Center for Biotechnology Information
  • Cyanobacteria also called cyanobacteria or cyanobacteria, are a group of prokaryotes that collect light energy with chlorophyll and electrolyze water with the obtained energy to generate oxygen while photosynthesizing. Cyanobacteria are rich in diversity, for example, in cell shape, there are unicellular species such as Synechocysis sp. PCC 6803 and multicellular filamentous species such as Anabaena sp. PCC 7120. Regarding the habitat, there are thermophilic species such as Thermosynechococcus elongatus, marine species such as Synechococcus elongatus, and freshwater species such as Synechocystis.
  • Microcystis aeruginosa a species that has gas vesicles and produces toxins
  • Gloeobacter violaceus which has a protein called phycobilisome that is a focusing antenna on the plasma membrane without thylakoids. There are many species that have.
  • FIG. 1 is a diagram schematically showing the cell surface layer of cyanobacteria.
  • the cell surface layer of cyanobacteria is composed of a plasma membrane (also referred to as inner membrane 1), peptidoglycan 2, and an outer membrane 5, which is a lipid membrane forming the outermost layer of cells, in this order from the inside.
  • a plasma membrane also referred to as inner membrane 1
  • peptidoglycan 2 and an outer membrane 5, which is a lipid membrane forming the outermost layer of cells, in this order from the inside.
  • a sugar chain 3 composed of glucosamine, mannosamine, etc. is covalently bound to peptidoglycan 2, and pyruvate is covalently bound to these covalently bound sugar chains 3 (Non-Patent Document 5: Jurgens and). Weckesser, 1986, J. Bacteriol., 168: 568-573).
  • the peptidoglycan 2 and the covalently bound sugar chain 3 are collectively referred to as a cell wall 4.
  • the gap between the plasma membrane (that is, the inner membrane 1) and the outer membrane 5 is called periplasm, and is called periplasm, which decomposes proteins or forms a three-dimensional structure, decomposes lipids or nucleic acids, or takes up extracellular nutrients.
  • periplasm which decomposes proteins or forms a three-dimensional structure, decomposes lipids or nucleic acids, or takes up extracellular nutrients.
  • periplasm which decomposes proteins or forms a three-dimensional structure, decomposes lipids or nucleic acids, or takes up extracellular nutrients.
  • enzymes involved in There are various enzymes involved in.
  • the SLH domain-retaining outer membrane protein (for example, Slr1841 in the figure) consists of a C-terminal region embedded in a lipid membrane (also referred to as outer membrane 5) and an N-terminal SLH domain 7 protruding from the lipid membrane.
  • Cyanobacteria and bacteria belonging to the Negativicutes family which is a group of gram-negative bacteria (Non-Patent Document 6: Kojima et al., 2016, Biosci. Biotech. Biochem., 10: 1954-1959).
  • the region embedded in the lipid membrane forms channels to allow the outer membrane of hydrophilic substances to permeate, while the SLH domain 7 has the function of binding to the cell wall 4 (non-adventitia).
  • Patent Document 7 Kowata et al., 2017, J. Bacteriol., 199: e00371-17).
  • the covalent sugar chain 3 in peptidoglycan 2 must be modified with pyruvic acid (Kojima et al., 2016, J. Biol. Chem., 291). : 20198-20209).
  • genes encoding SLH domain-bearing outer membrane protein 6 include slr1841 or slr1908 carried by Synechocysis sp. PCC 6803, or oprB held by Anabaena sp. 90.
  • the enzyme that catalyzes the pyruvate modification reaction of the covalent sugar chain 3 in peptidoglycan 2 (hereinafter referred to as cell wall-pyruvate modifying enzyme 9) has been identified in the Gram-positive bacterium Bacillus anthracis and is named CsaB.
  • Non-Patent Document 8 Mesnage et al., 2000, EMBO J., 19: 4473-4484.
  • cyanobacteria whose genomic nucleotide sequence is open to the public, many species carry a gene encoding a homologous protein having an amino acid sequence identity of 30% or more with CsaB. Examples include slr0688 held by Synechococcus sp. PCC 6803 or synpcc7502_03092 held by Synechococcus sp. 7502.
  • cyanobacteria CO 2 immobilized by photosynthesis is converted into various amino acids through a multi-step enzymatic reaction. Using them as raw materials, proteins are synthesized in the cytoplasm of cyanobacteria. Some of these proteins function within the cytoplasm, while others are transported from the cytoplasm to the periplasm and function within the periplasm. However, cases of active secretion of proteins extracellularly have not been reported in cyanobacteria to date.
  • Cyanobacteria have high photosynthetic ability, so it is not always necessary to take in organic matter as nutrients from the outside. Therefore, cyanobacteria have very few channel proteins on the outer membrane 5 that allow organic matter to permeate, such as the organic channel protein 8 (eg, Slr1270) in FIG.
  • the organic channel protein 8 eg, Slr1270
  • the organic channel protein 8 that allows the organic matter to permeate is present in only about 4% of the total protein amount of the outer membrane 5.
  • cyanobacteria permeate only inorganic ions like SLH domain-retaining outer membrane protein 6 (for example, Slr1841) in FIG.
  • the outer membrane 5 has a large amount of ion channel proteins to cause.
  • the ion channel proteins that allow inorganic ions to permeate account for about 80% of the total protein content of the outer membrane 5.
  • the functions of proteins involved in the binding between the outer membrane 5 and the cell wall 4 are suppressed or lost.
  • binding-related proteins proteins involved in the binding between the outer membrane 5 and the cell wall 4
  • the binding between the outer membrane 5 and the cell wall 4 for example, the binding amount and the binding force
  • the modified cyanobacteria improve the secretory productivity of the protein that secretes the protein produced in the cell to the outside of the cell.
  • the modified cyanobacteria can be repeatedly used to produce the protein even after the protein is recovered.
  • production the secretion of the produced protein outside the cell.
  • the protein involved in the binding between the outer membrane 5 and the cell wall 4 may be, for example, at least one of the SLH domain-retaining outer membrane protein 6 and the cell wall-pyruvic acid modifying enzyme 9.
  • the modified cyanobacteria for example, suppress or lose the function of at least one protein of SLH domain-retaining outer membrane protein 6 and cell wall-pyruvic acid modifying enzyme 9.
  • at least one function of (i) SLH domain-retaining outer membrane protein 6 and cell wall-pyruvate modifying enzyme 9 may be suppressed or lost, and (ii) SLH domain that binds to cell wall 4.
  • At least one of the expression of the retained outer membrane protein 6 and the enzyme that catalyzes the pyruvate modification reaction of the bound sugar chain on the surface of the cell wall 4 may be suppressed. ..
  • the binding that is, the binding amount and binding force
  • the outer membrane 5 is likely to be detached from the cell wall 4 at the portion where these bonds are weakened.
  • the partial detachment of the outer membrane 5 from the cell wall 4 facilitates the leakage of proteins present in the intracellular cyanobacteria, especially in the periplasm, to the outside of the cell (outside the outer membrane 5).
  • cyanobacteria have high photosynthetic ability, so it is not always necessary to take in organic matter as nutrients from the outside. Therefore, the culture of cyanobacteria needs only light, air, water, and a trace amount of inorganic substances, and the cyanobacteria take up the inorganic substances into the cells through the ion channels of the outer membrane 5 and produce proteins in the cells. In particular, various proteins are present in the periplasm of the void between the outer membrane 5 and the cell wall 4. In the modified cyanobacteria according to the present embodiment, the function of the protein involved in the binding between the outer membrane 5 and the cell wall 4 is suppressed or lost. As a result, the outer membrane 5 is likely to be partially detached from the cell wall 4.
  • the modified cyanobacteria improve the secretory productivity of the protein that secretes the protein produced in the cell to the outside of the cell.
  • the outer membrane 5 is modified to partially detach from the cell wall 4 by suppressing the functions of at least one binding-related protein of the SLH domain-retaining outer membrane protein 6 and the cell wall-pyruvic acid modifying enzyme 9.
  • the cyanobacteria will be described more specifically.
  • the type of (hereinafter referred to as parent cyanobacteria) is not particularly limited, and may be any type of cyanobacteria.
  • the parent cyanobacteria may be of the genus Synechococcus, Synechococcus, Anabaena, or Thermosynechococcus, among which Synechococcus sp. PCC 6803, Synechococcus sp. PCC 7942, or Thermosynechococcus elongatus BP-1. May be good.
  • the base sequence and the position of the gene on the chromosomal DNA or plasmid can be confirmed by the above-mentioned NCBI database and Cyanobase.
  • the SLH domain-retaining outer membrane protein 6 and the cell wall-plasmid acid modifying enzyme 9 whose functions are suppressed or lost in the modified cyanobacteria according to the present embodiment are any parent as long as they are possessed by the parent cyanobacteria. It may be of cyanobacteria and is not limited by the location of the genes encoding them (eg, on chromosomal DNA or plasmid).
  • the SLH domain-retaining outer membrane protein 6 may be Slr1841, Slr1908, Slr0042, etc. when the parent cyanobacteria belongs to the genus Synchocystis, or NIES970_09470 or the like when the parent cyanobacteria belongs to the genus Synechococcus.
  • the parent cyanobacteria belongs to the genus Anabaena, it may be Anacy_5815 or Anacy_3458, etc.
  • the parent cyanobacteria belongs to the genus Microcystis it may be A0A0F6U6F8_MICAE, etc.
  • the parent cyanobacteria belongs to the genus Leptolyngbya, it may be A0A1Q8ZE23_9CYAN, etc., if the parent cyanobacteria belongs to the genus Calothrix, it may be A0A1Z4R6U0_9CYAN, and if the parent cyanobacteria belongs to the genus Nostoc, it may be A0A1C0VG86_9NOSO.
  • the parent cyanobacteria belongs to the genus Crocosphaera, it may be B1WRN6_CROS5 or the like, and if the parent cyanobacteria belongs to the genus Pleurocapsa, it may be K9TAE4_9CYAN or the like.
  • the SLH domain-retaining outer membrane protein 6 is, for example, Slr1841 (SEQ ID NO: 1) of Synechococcus sp. PCC 6803, NIES970_09470 (SEQ ID NO: 2) of Synechococcus sp. NIES-970, or Anabaena cylindrica PCC. It may be Anacy_3458 (SEQ ID NO: 3) of 7122 or the like. Further, it may be a protein having an amino acid sequence of 50% or more identical to these SLH domain-retaining outer membrane proteins 6.
  • any SLH domain-retaining outer membrane protein 6 shown in SEQ ID NOs: 1 to 3 above, or any of these SLH domain-retaining outer membrane proteins 6 and amino acids may be suppressed or lost, and (ii) any SLH domain-retaining outer membrane protein 6 shown in SEQ ID NOs: 1 to 3 above, or any of these.
  • the expression of a protein having an amino acid sequence that is 50% or more identical to that of SLH domain-retaining outer membrane protein 6 may be suppressed.
  • the modified cyanobacteria (i) the function of the SLH domain-retaining outer membrane protein 6 or the protein having the same function as the SLH domain-retaining outer membrane protein 6 in the outer membrane 5 is suppressed or lost, or (Ii) The expression level of the SLH domain-retaining outer membrane protein 6 or the protein having the same function as the SLH domain-retaining outer membrane protein 6 in the outer membrane 5 is reduced. Therefore, in the modified cyanobacteria according to the present embodiment, the binding amount and binding force for the binding domain (for example, SLH domain 7) for the outer membrane 5 to bind to the cell wall 4 are reduced, so that the outer membrane 5 is bound to the cell wall 4. The membrane 5 tends to partially detach from the cell wall 4.
  • the SLH domain-retaining outer membrane protein 6 whose function is suppressed or lost includes, for example, 40% of the amino acid sequence of any of the SLH domain-retaining outer membrane proteins shown in SEQ ID NOs: 1 to 3 above.
  • the cell wall 4 comprises an amino acid sequence having an identity of preferably 50% or more, more preferably 60% or more, further preferably 70% or more, still more preferably 80% or more, still more preferably 90% or more. It may be a protein or polypeptide having a function of binding to the covalent bond type sugar chain 3.
  • the cell wall-pyruvate modifying enzyme 9 may be Slr0688 or the like when the parent cyanobacteria belongs to the genus Synchocystis, or may be Syn7502_03092 or Synpcc7942_1529 or the like when the parent cyanobacteria belongs to the genus Synechococcus.
  • the cyanobacteria belongs to the genus Anabaena, it may be ANA_C20348 or Anacy_1623, etc.
  • the parent cyanobacteria belongs to the genus Microcystis, it may be CsaB (NCBI access ID: TRU80220), etc.
  • the parent cyanobacteria belongs to the genus Cyanothese.
  • it may be CsaB (NCBI access ID: WP_107667006.1) or the like
  • the parent cyanobacteria belongs to the genus Spirulina
  • it may be CsaB (NCBI access ID: WP_026079530.1) or the like.
  • CsaB NCBI access ID: WP_096658142.1
  • the parent cyanobacteria is of the genus Nostoc
  • it may be CsaB (NCBI access ID: WP_099068528.1) or the like.
  • the parent cyanobacteria belongs to the genus Crocosphaera, it may be CsaB (NCBI access ID: WP_012361697.1), etc.
  • the parent cyanobacteria belongs to the genus Pleurocapsa it may be CsaB (NCBI access ID: WP_036798735), etc. May be good.
  • the cell wall-pyruvic acid modifying enzyme 9 is, for example, Slr0688 (SEQ ID NO: 4) of Synechococcus sp. PCC 6803, Synpcc 7942_1529 (SEQ ID NO: 5) of Synechococcus sp. PCC 7942, or Anabaena cylindrica PCC 7122. It may be Anacy_1623 (SEQ ID NO: 6) or the like. Further, it may be a protein having an amino acid sequence of 50% or more identical to these cell wall-pyruvic acid modifying enzymes 9.
  • any cell wall-pyruvate modifying enzyme 9 shown in SEQ ID NOs: 4 to 6 above, or any of these cell walls-pyrvanoic acid modifying enzyme 9 and an amino acid sequence can be obtained.
  • the function of proteins that are 50% or more identical is suppressed or lost, or (ii) any cell wall set forth in SEQ ID NOs: 4 to 6 above-the cell wall of pyruvate modifying enzyme 9 or any of these-.
  • the expression of a protein having an amino acid sequence that is 50% or more identical to that of pyruvate modifying enzyme 9 is suppressed.
  • the function of the cell wall-pyruvic acid modifying enzyme 9 or a protein having a function equivalent to the enzyme is suppressed or lost, or (ii) the cell wall-pyruvic acid modifying enzyme 9 or the said
  • the expression level of proteins having the same function as enzymes is reduced.
  • the covalently bound sugar chain 3 on the surface of the cell wall 4 is less likely to be modified with pyruvic acid, so that the sugar chain 3 of the cell wall 4 becomes the SLH domain 7 of the SLH domain-retaining outer membrane protein 6 in the outer membrane 5.
  • the amount of binding and the binding force are reduced.
  • the covalently bound sugar chain 3 on the surface of the cell wall 4 is less likely to be modified with pyruvic acid, so that the binding force between the cell wall 4 and the outer membrane 5 is weakened and the outer membrane 5 is weakened. 5 is likely to partially detach from the cell wall 4.
  • the cell wall-pyruvate modifying enzyme 9 whose function is suppressed or lost includes, for example, 40% or more of the amino acid sequence of any of the cell wall-pyruvate modifying enzymes 9 shown in SEQ ID NOs: 4 to 6 above.
  • Peptidoglycan consisting of an amino acid sequence having an amino acid sequence of preferably 50% or more, more preferably 60% or more, still more preferably 70% or more, even more preferably 80% or more, still more preferably 90% or more, and having cell wall 4 peptide glycan. It may be a protein or polypeptide having a function of catalyzing a reaction of modifying the covalent sugar chain 3 of 2 with pyruvate.
  • suppressing or losing the function of SLH domain-retaining outer membrane protein 6 means suppressing or losing the ability of the protein to bind to the cell wall 4, and to the outer membrane 5 of the protein.
  • the transport of the protein is suppressed or lost, or the ability of the protein to implant and function in the outer membrane 5 is suppressed or lost.
  • suppressing or losing the function of the cell wall-pyruvic acid modifying enzyme 9 means that the protein suppresses or loses the function of modifying the covalent sugar chain 3 of the cell wall 4 with pyruvic acid.
  • the means for suppressing or losing the function of these proteins is not particularly limited as long as it is a means usually used for suppressing or losing the function of the protein.
  • the means include, for example, deleting or inactivating the gene encoding the SLH domain-retaining outer membrane protein 6 and the gene encoding the cell wall-pyruvate modifying enzyme 9, and inhibiting the transcription of these genes. It may be to inhibit the translation of transcripts of these genes, or to administer an inhibitor that specifically inhibits these proteins.
  • the modified cyanobacteria may have the gene expressing the protein involved in the binding between the outer membrane 5 and the cell wall 4 deleted or inactivated.
  • the expression of the protein involved in the binding between the cell wall 4 and the outer membrane 5 is suppressed, or the function of the protein is suppressed or lost. (So-called binding amount and binding force) is partially reduced.
  • the outer membrane 5 is more likely to be partially detached from the cell wall 4, so that the protein produced in the cells is more likely to leak out of the outer membrane 5, that is, to the outside of the cells.
  • the modified cyanobacteria according to the present embodiment improve the secretory productivity of the protein that secretes the protein produced in the cell to the outside of the cell.
  • the modified cyanobacteria can be repeatedly used to produce the protein even after the protein is recovered.
  • the gene that expresses the protein involved in the binding between the outer membrane 5 and the cell wall 4 is, for example, at least one of the gene encoding the SLH domain-retaining outer membrane protein 6 and the gene encoding the cell wall-pyruvate modifying enzyme 9. There may be.
  • the modified cyanobacteria at least one gene encoding the SLH domain-retaining outer membrane protein 6 and the gene encoding the cell wall-pyruvic acid modifying enzyme 9 are deleted or inactivated. Therefore, in the modified cyanobacteria, for example, the expression of at least one of (i) SLH domain-retaining outer membrane protein 6 and cell wall-pyruvate modifying enzyme 9 is suppressed, or (ii) SLH domain-retaining outer membrane protein.
  • the binding that is, the binding amount and binding force
  • the outer membrane 5 is likely to be detached from the cell wall 4 at the portion where the bond between the outer membrane 5 and the cell wall 4 is weakened. Therefore, according to the modified cyanobacteria according to the present embodiment, the outer membrane 5 is easily detached from the cell wall 4 by reducing the binding between the outer membrane 5 and the cell wall 4, so that the outer membrane 5 is produced in the cells. The protein is likely to leak out of the cells.
  • SLH domain-retaining outer membrane protein 6 is used to suppress or eliminate at least one function of SLH domain-retaining outer membrane protein 6 and cell wall-pyruvate modifying enzyme 9 in cyanobacteria.
  • the encoding gene and the cell wall-the transcription of at least one of the genes encoding the pyruvate modifying enzyme 9 may be suppressed.
  • the gene encoding SLH domain-bearing outer membrane protein 6 may be slr1841, slr1908, slr0042, etc. when the parent cyanobacteria belongs to the genus Syenchocystis, or may be nies970_09470, etc. in the case of the genus Synechococcus.
  • the parent cyanobacteria belongs to the genus Anabaena, it may be anacy_5815 or anacy_3458, etc.
  • the parent cyanobacteria belongs to the genus Microcystis it may be A0A0F6U6F8_MICAE, etc.
  • the parent cyanobacteria belongs to the genus Leptolyngbya, it may be A0A1Q8ZE23_9CYAN, etc., if the parent cyanobacteria belongs to the genus Calothrix, it may be A0A1Z4R6U0_9CYAN, etc., if the parent cyanobacteria belongs to the genus Nostoc, A0A1C0VG86_9NOSO, etc.
  • the parent cyanobacteria belongs to the genus Crocosphaera, it may be B1WRN6_CROS5 or the like, and if the parent cyanobacteria belongs to the genus Pleurocapsa, it may be K9TAE4_9CYAN or the like.
  • the nucleotide sequences of these genes can be obtained from the NCBI database described above or Cyanobase.
  • genes encoding SLH domain-retaining outer membrane protein 6 are slr1841 (SEQ ID NO: 7) of Synechococcus sp. PCC 6803, nies970_09470 (SEQ ID NO: 8) of Synechococcus sp. NIES-970, and Anabaena cylindrica PCC. It may be anacy_3458 (SEQ ID NO: 9) of 7122, or a gene whose amino acid sequence is 50% or more identical to these genes.
  • the modified cyanobacteria As a result, in the modified cyanobacteria, it is 50% or more identical to the gene encoding any of the SLH domain-bearing outer membrane proteins 6 shown in SEQ ID NOs: 7 to 9 above or the base sequence of any of these genes. The gene is deleted or inactivated. Therefore, in the modified cyanobacteria, (i) expression of any of the above SLH domain-retaining outer membrane proteins 6 or a protein having a function equivalent to that of any of these proteins is suppressed, or (ii) the above. The function of any of the SLH domain-retaining outer membrane proteins 6 or a protein having a function equivalent to that of any of these proteins is suppressed or lost.
  • the binding amount and binding force of the binding domain (for example, SLH domain 7) for the outer membrane 5 to bind to the cell wall 4 are reduced, so that the outer membrane is reduced. 5 tends to partially detach from the cell wall 4.
  • the amino acid sequence of a protein is 30% or more the same, it is said that there is a high possibility that it has the same function as the protein. Therefore, if the base sequence of the gene encoding the protein is 30% or more the same, it is considered that there is a high possibility that a protein having the same function as the protein will be expressed. Therefore, the gene encoding the SLH domain-retaining outer membrane protein 6 whose function is suppressed or lost is, for example, any of the genes encoding the SLH domain-retaining outer membrane protein 6 shown in SEQ ID NOs: 7 to 9 above.
  • the gene encoding the cell wall-pyruvate modifying enzyme 9 may be slr0688 or the like when the parent cyanobacteria belongs to the genus Synchocystis, or syn7502_03092 or synpcc7942_1529 or the like when the parent cyanobacteria belongs to the genus Synechococcus. If the parent cyanobacteria belongs to the genus Anabaena, it may be ana_C20348 or anacy_1623, etc., and if the parent cyanobacteria belongs to the genus Microcystis, it may be csaB (NCBI access ID: TRU80220), etc.
  • Cynahothese it may be csaB (NCBI access ID: WP_107667006.1), etc., and if the parent cyanobacteria is Spirulina, it may be csaB (NCBI access ID: WP_026079530.1), etc.
  • the parent cyanobacteria belongs to the genus Calothrix, it may be csaB (NCBI access ID: WP_096658142.1), etc.
  • the parent cyanobacteria belongs to the genus Nostoc it may be csaB (NCBI access ID: WP_099068528.1), etc.
  • the parent cyanobacteria belongs to the genus Crocosphaera, it may be csaB (NCBI access ID: WP_012361697.1), etc., and if the parent cyanobacteria belongs to the genus Pleurocapsa, csaB (NCBI access ID: WP_036798735). And so on.
  • the nucleotide sequences of these genes can be obtained from the NCBI database described above or Cyanobase.
  • the gene encoding the cell wall-pyruvic acid modifying enzyme 9 is slr0688 (SEQ ID NO: 10) of Synechococcus sp. PCC 6803, synpcc7942_1529 (SEQ ID NO: 11) of Synechococcus sp. PCC 7942, or Anabaena cylindrica PCC. It may be anacy_1623 (SEQ ID NO: 12) of 7122. Moreover, it may be a gene whose base sequence is 50% or more identical to these genes.
  • the modified cyanobacteria 50% or more of the base sequence of the gene encoding any cell wall-pyruvic acid modifying enzyme 9 shown in SEQ ID NOs: 10 to 12 above or the gene encoding any of these enzymes. Genes that are identical are deleted or inactivated. Therefore, in the modified cyanobacteria, (i) expression of any of the above cell wall-pyruvic acid modifying enzymes 9 or a protein having a function equivalent to that of any of these enzymes is suppressed, or (ii) the above. The function of any cell wall-pyruvic acid modifying enzyme 9 or a protein having a function equivalent to that of any of these enzymes is suppressed or lost.
  • the covalently bound sugar chain 3 on the surface of the cell wall 4 is less likely to be modified with pyruvic acid, so that the sugar chain 3 of the cell wall 4 becomes the SLH domain 7 of the SLH domain-retaining outer membrane protein 6 in the outer membrane 5.
  • the amount of binding and the binding force are reduced. Therefore, in the modified cyanobacteria according to the present embodiment, the amount of the sugar chain 3 for binding the cell wall 4 to the outer membrane 5 is reduced by pyruvic acid, so that the binding force between the cell wall 4 and the outer membrane 5 is reduced. Is weakened, and the outer membrane 5 is likely to partially detach from the cell wall 4.
  • the gene encoding the cell wall-pyruvate modifying enzyme 9 whose function is suppressed or lost is, for example, any of the genes encoding the cell wall-pyruvate modifying enzyme 9 shown in SEQ ID NOs: 10 to 12 above. From a base sequence having 40% or more, preferably 50% or more, more preferably 60% or more, still more preferably 70% or more, still more preferably 80% or more, still more preferably 90% or more identity with the base sequence. It may also be a gene encoding a protein or polypeptide having a function of catalyzing a reaction of modifying the covalent sugar chain 3 of the peptidoglycan 2 of the cell wall 4 with pyruvate.
  • the method for producing a modified cyanobacteria comprises a step of suppressing or abolishing the function of a protein involved in the binding of the outer membrane 5 to the cell wall 4 in the cyanobacteria.
  • the protein involved in the binding between the outer membrane 5 and the cell wall 4 may be, for example, at least one of the SLH domain-retaining outer membrane protein 6 and the cell wall-pyruvic acid modifying enzyme 9.
  • the means for suppressing or losing the function of the protein is not particularly limited, but for example, the gene encoding the SLH domain-retaining outer membrane protein 6 and the gene encoding the cell wall-pyruvate modifying enzyme 9 are deleted or deleted. Even by inactivating, inhibiting the transcription of these genes, inhibiting the translation of transcripts of these genes, or administering inhibitors that specifically inhibit these proteins, etc. Good.
  • the means for deleting or inactivating the above gene is, for example, introduction of a mutation for one or more bases on the base sequence of the relevant gene, substitution of the relevant base sequence with another base sequence, or replacement of another base sequence. It may be inserted, or part or all of the base sequence of the relevant gene may be deleted.
  • the means for inhibiting transcription of the gene is, for example, introduction of a mutation into the promoter region of the gene, inactivation of the promoter by substitution with another base sequence or insertion of another base sequence, or CRISPR interferometry (non-).
  • Patent Document 9 Yao et al., ACS Synth. Biol., 2016, 5: 207-212) and the like may be used.
  • the specific method for introducing the mutation or substituting or inserting the base sequence may be, for example, ultraviolet irradiation, site-specific mutation introduction, or homologous recombination method.
  • the means for inhibiting the translation of the transcript of the above gene may be, for example, RNA (ribonucleic acid) interferometry or the like.
  • the modified cyanobacteria may be produced by suppressing or losing the function of the protein involved in the binding between the outer membrane 5 and the cell wall 4 in the cyanobacteria.
  • the binding that is, the binding amount and binding force
  • the outer membrane 5 is formed. It becomes easy to partially detach from the cell wall 4. Therefore, in the modified cyanobacteria, the protein produced in the cells is likely to leak out of the outer membrane 5 (that is, outside the cells). Therefore, according to the method for producing modified cyanobacteria according to the present embodiment, it is possible to provide modified cyanobacteria having improved protein secretion productivity.
  • the protein produced in the cells leaks out of the cells, so that it is not necessary to crush the cells in order to recover the protein.
  • the modified cyanobacteria since the modified cyanobacteria may be cultured under appropriate conditions and then the protein secreted into the culture solution may be recovered, it is possible to recover the protein in the culture solution while culturing the modified cyanobacteria. Therefore, efficient microbiological protein production can be carried out by using the modified cyanobacteria obtained by this production method. Therefore, according to the method for producing modified cyanobacteria according to the present embodiment, it is possible to provide a highly efficient modified cyanobacteria that can be used repeatedly even after the protein is recovered.
  • the modified cyanobacteria produced by the method for producing modified cyanobacteria according to the present embodiment secretes a group of proteins originally present in periplasm, such as peptidase or phosphatase, extracellularly.
  • a gene encoding a protein originally produced in a cyanobacterial cell, such as a group of proteins existing in periplasm is modified and replaced with a gene encoding another protein.
  • the modified cyanobacteria produce the desired protein. Therefore, according to the method for producing modified cyanobacteria according to the present embodiment, it is also possible to provide modified cyanobacteria capable of easily and efficiently producing a desired protein.
  • the method for producing a protein according to the present embodiment includes the step of culturing the above-mentioned modified cyanobacteria.
  • Cyanobacterial culture can generally be carried out based on liquid culture using BG-11 medium (see Table 2) or a modified method thereof. Therefore, the culture of modified cyanobacteria may be carried out in the same manner.
  • the culture period of cyanobacteria for producing the protein may be a period during which the protein can be accumulated at a high concentration under the condition that the cells have sufficiently grown, for example, 1 to 3 days. It may be 4 to 7 days.
  • the culture method may be, for example, aeration stirring culture or shaking culture.
  • the modified cyanobacteria By culturing under the above conditions, the modified cyanobacteria produce a protein in the cells and secrete the protein into the culture medium.
  • the culture solution When recovering the protein secreted into the culture solution, the culture solution is filtered or centrifuged to remove solids such as cells (so-called bacterial cells) from the culture solution, and the culture supernatant is collected. You may.
  • the modified cyanobacteria remaining after the protein recovery can be repeatedly used to produce the protein.
  • the method for recovering the protein secreted in the culture solution is not limited to the above example, and the protein in the culture solution may be recovered while culturing the modified cyanobacteria.
  • the protein that has permeated the permeable membrane may be recovered by using a permeable membrane that permeates the protein.
  • useful microorganisms such as lactic acid bacteria may be cultured using the protein that has permeated the permeable membrane as a nutrient source.
  • the protein in the culture solution can be recovered while culturing the modified cyanobacteria, the treatment for removing the cells of the modified cyanobacteria from the culture solution becomes unnecessary. Therefore, the protein can be produced more easily and efficiently.
  • the damage and stress received by the modified cyanobacteria can be reduced by eliminating the need for the recovery treatment of the bacterial cells from the culture solution and the crushing treatment of the bacterial cells. Therefore, it becomes difficult to reduce the secretory productivity of the modified cyanobacterial protein, and the modified cyanobacteria can be used for a longer period of time.
  • an enzyme for producing a food ingredient raw material or a compound, a diagnostic enzyme or a therapeutic enzyme in the medical field, or agricultural water Feed enzymes and the like in the livestock field can be easily and efficiently obtained.
  • the modified cyanobacteria of the present disclosure the method for producing the modified cyanobacteria, and the method for producing the protein will be specifically described in Examples, but the present disclosure is not limited to the following Examples.
  • cyanobacteria As a method for partially removing the outer membrane of cyanobacteria from the cell wall, expression suppression of the slr1841 gene encoding an SLH domain-retaining outer membrane protein (Example 1) and cell wall-pyruvate modification The expression of the slr0688 gene encoding the enzyme was suppressed (Example 2), and two types of modified cyanobacteria were produced. Then, the secretory productivity of these modified cyanobacterial proteins was measured, and the secreted proteins were identified.
  • the cyanobacterial species used in this example is Synechocystis sp. PCC 6803 (hereinafter, simply referred to as “cyanobacteria”).
  • Example 1 In Example 1, a modified cyanobacteria in which the expression of the slr1841 gene encoding the SLH domain-retaining outer membrane protein was suppressed was produced.
  • a cyanobacterial modified strain in which the expression of the slr1841 gene was suppressed As a gene expression suppression method, a CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) interferometry was used. In this method, the expression of the slr1841 gene is suppressed by introducing the gene encoding the dCas9 protein (hereinafter referred to as the dCas9 gene) and the slr1841_sgRNA (single-guide Ribonucleic Acid) gene into the chromosomal DNA of cyanobacteria. Can be done.
  • the dCas9 protein hereinafter referred to as the dCas9 gene
  • slr1841_sgRNA single-guide Ribonucleic Acid
  • the mechanism of gene expression suppression by this method is as follows.
  • the Cas9 protein lacking nuclease activity and the sgRNA (slr1841_sgRNA) that complementarily binds to the base sequence of the slr1841 gene form a complex.
  • this complex recognizes the slr1841 gene on the chromosomal DNA of cyanobacteria and specifically binds to the slr1841 gene.
  • this binding becomes steric hindrance, transcription of the slr1841 gene is inhibited.
  • the expression of the cyanobacterial slr1841 gene is suppressed.
  • the above three genes are inserted into the psbA1 gene on the chromosomal DNA in a linked state, they can be amplified as one DNA fragment by the PCR method.
  • the obtained DNA fragment is referred to as "psbA1 :: dCas9 cassette".
  • the psbA1 :: dCas9 cassette was inserted into the pUC19 plasmid to obtain the pUC19-dCas9 plasmid.
  • Transformed cells were selected by growing on BG-11 agar medium containing 20 ⁇ g / mL spectinomycin. In the selected cells, homologous recombination occurs between the psbA1 gene on the chromosomal DNA and the psbA1 upstream fragment region and the psbA1 downstream fragment region on the pUC19-dCas9 plasmid.
  • a Synechocystis dCas9 strain in which a dCas9 cassette was inserted into the psbA1 gene region was obtained.
  • the composition of the BG-11 medium used is as shown in Table 2.
  • sgRNA specifically binds to the target gene by introducing a sequence of about 20 bases complementary to the target sequence into the region called protospacer on the sgRNA gene. To do.
  • the protospacer sequences used in this example are shown in Table 3.
  • the sgRNA gene (excluding the protospacer region) and the kanamycin resistance marker gene are linked and inserted into the slr2030-slr2031 gene on the chromosomal DNA. Therefore, by adding a protospacer sequence (SEQ ID NO: 21) complementary to the slr1841 gene (SEQ ID NO: 7) to the primer used when amplifying the sgRNA gene by the PCR method, sgRNA (slr1841_sgRNA) that specifically recognizes slr1841 ) Can be easily obtained.
  • amplification by the PCR method using the primers slr2030-Fw (SEQ ID NO: 15) and slr2031-Rv (SEQ ID NO: 18) shown in Table 1 was carried out to obtain ((SEQ ID NO: 15).
  • a DNA fragment (slr2030-2031 :: slr1841_sgRNA) was obtained in which i) slr2030 gene fragment, (ii) slr1841_sgRNA, (iii) kanamycin resistance marker gene, and (iv) slr2031 gene fragment were linked in this order.
  • slr2030-2031 Using the In-Fusion PCR cloning method (registered trademark), slr2030-2031 :: slr1841_sgRNA was inserted into the pUC19 plasmid to obtain the pUC19-slr1841_sgRNA plasmid.
  • the pUC19-slr1841_sgRNA plasmid was introduced into Synechocystis dCas9 strain by the same method as in (1-1) above, and transformed cells were selected on BG-11 agar medium containing 30 ⁇ g / mL kanamycin.
  • a transformant Synechocystis dCas9 slr1841_sgRNA strain (hereinafter, also referred to as slr1841 inhibitory strain) in which slr1841_sgRNA was inserted into the slr2030-slr2031 gene on the chromosomal DNA was obtained.
  • Example 2 a modified cyanobacteria in which the expression of the slr0688 gene encoding the cell wall-pyruvic acid modifying enzyme was suppressed was obtained by the following procedure.
  • In-Fusion PCR was used and DNA fragments (slr2030-2031 :: slr0688_sgRNA) in which (i) slr2030 gene fragment, (ii) slr0688_sgRNA, (iii) canamycin resistance marker gene, and (iv) slr2031 gene fragment were linked in order.
  • Comparative Example 1 a Synechocystis dCas9 strain was obtained by the same procedure as in (1-1) of Example 1.
  • Example 1 Example 2 and Comparative Example 1
  • the state of the cell surface layer was observed and the protein secretion productivity test was carried out, respectively. The details will be described below.
  • the cells in the resin were sliced to a thickness of 70 nm using an ultramicrotome (Ultracut) to prepare ultrathin sections.
  • This ultrathin section was stained with 2% uranium acetate and 1% lead citrate solution to prepare a transmission electron microscope sample of the slr1841 inhibitor strain of Example 1.
  • the same operation was performed for the slr0688-suppressed strain of Example 2 and the Control strain of Comparative Example 1, and samples for a transmission electron microscope were prepared.
  • FIG. 2 is a TEM (Transmission Electron Microscope) image of the slr1841 inhibitory strain of Example 1.
  • FIG. 3 is an enlarged image of the broken line region A of FIG.
  • FIG. 3A is an enlarged TEM image of the broken line region A of FIG. 2
  • FIG. 3B is a diagram depicting an enlarged TEM image of FIG. 3A.
  • the adventitia was partially exfoliated from the cell wall (that is, the adventitia was partially exfoliated) and the adventitia was partially flexed. There was.
  • the outer membrane was partially peeled off as shown in FIGS. 3 (a) and 3 (b).
  • the parts one-dot dashed line areas a1 and a2 in the figure
  • a portion where the outer membrane was greatly bent could be confirmed near the one-dot dashed line region a1.
  • This part is a part where the bond between the outer membrane and the cell wall is weakened, and it is considered that the outer membrane is expanded outward and bent because the culture solution permeated into the periplasm from the outer membrane.
  • FIG. 4 is a TEM image of the slr0688 inhibitory strain of Example 2.
  • FIG. 5 is an enlarged image of the broken line region B of FIG.
  • FIG. 5A is an enlarged TEM image of the broken line region B of FIG. 4
  • FIG. 5B is a diagram depicting an enlarged TEM image of FIG. 5A.
  • FIG. 6 is a TEM image of the Control strain of Comparative Example 1.
  • FIG. 7 is an enlarged image of the broken line region C of FIG.
  • FIG. 7A is an enlarged TEM image of the broken line region C of FIG. 6, and
  • FIG. 7B is a diagram depicting an enlarged TEM image of FIG. 7A.
  • the cell surface layer of the Control strain of Comparative Example 1 was in order, and the inner membrane, the cell wall, the outer membrane, and the S layer were kept laminated in this order. That is, in the Control strain, the portion where the outer membrane was detached from the cell wall, the portion where the outer membrane was detached from the cell wall (that is, peeled off), and the portion where the outer membrane was bent as in Examples 1 and 2 were I could't see it.
  • Example 4 Culturing of strain
  • the slr1841 inhibitory strain of Example 1 was cultured in the same manner as in (3-1) above. The culture was independently performed 3 times. The strains of Example 2 and Comparative Example 1 were also cultured under the same conditions as those of Example 1.
  • both the slr1841 inhibitory strain of Example 1 and the slr0688 inhibitory strain of Example 2 had the amount of protein secreted in the culture supernatant (mg / mg /) as compared with the Control strain of Comparative Example 1. L) was improved about 25 times.
  • the gene encoding the cell wall-pyruvate modifying enzyme (slr1841) is higher than that of the slr1841 inhibitory strain of Example 1 in which the expression of the gene encoding the SLH domain-retaining outer membrane protein (slr1841) is suppressed (slr1841).
  • the slr0688-suppressed strain of Example 2 in which the expression of slr0688) was suppressed had a larger amount of protein secreted in the culture supernatant. This may be related to the fact that the number of covalent sugar chains on the cell wall surface is larger than the number of SLH domain-retaining outer membrane proteins (Slr1841) in the outer membrane.
  • Example 2 since the slr0688-suppressed strain of Example 2 had a lower binding amount and binding force between the outer membrane and the cell wall than the slr1841-suppressed strain of Example 1, the amount of secreted protein suppressed slr1841 of Example 1. It is thought that there were more than stocks.
  • IAA iodoacetamide
  • cysteine with a final concentration of 60 mM was added and allowed to stand at room temperature for 10 minutes.
  • 400 ng of trypsin was added and allowed to stand overnight at 37 ° C. to fragment the protein into peptide fragments.
  • TFA Trifluoroacetic Acid
  • the sample was dried by a centrifugal evaporator. Then, 3% acetonitrile and 0.1% formic acid were added, and the sample was dissolved using a closed ultrasonic crusher. The peptide concentration was adjusted to 200 ng / ⁇ L.
  • Table 4 shows 10 types of proteins in order from the one with the largest relative quantitative value among the identified proteins.
  • the modified cyanobacteria of the present disclosure secrete proteins existing in the cells (here, in the periplasm) to the outside of the cells. Because the modified cyanobacteria of the present disclosure can be genetically modified to produce other proteins, for example, in place of the protein identified above (ie, the protein originally produced in the cell). The desired protein can be efficiently produced. In addition, since cyanobacteria have high photosynthetic ability, they can easily obtain the required protein at the required time by culturing with light, water, air, and a trace amount of inorganic substances, so that the protein can be produced. There is no need to use complicated equipment. In addition, proteins tend to lose their function when processed into, for example, supplements. Therefore, according to the modified cyanobacteria of the present disclosure, it is possible to provide a protein while maintaining the function of the protein. Due to the above advantages, the modified cyanobacteria of the present disclosure are expected to be applied in various fields.
  • modified cyanobacteria The modified cyanobacteria, the method for producing the modified cyanobacteria, and the method for producing the protein according to the present disclosure have been described above based on the embodiments, but the present disclosure is not limited to these embodiments. As long as the gist of the present disclosure is not deviated, various modifications that can be conceived by those skilled in the art are applied to the embodiment, and other forms constructed by combining some components in the embodiment are also included in the scope of the present disclosure. included.
  • a protein produced in a cell is leaked to the outside of the cell by suppressing or losing the function of a protein involved in the binding between the outer membrane and the cell wall in cyanobacteria.
  • the bond between the outer membrane and the cell wall may be weakened, or the outer membrane may be weakened.
  • the outer membrane may be weakened by adding the enzyme or the drug to the culture solution of cyanobacteria.
  • the method for producing the modified cyanobacteria and the method for producing a protein using the modified cyanobacteria, water, light, air, and a trace amount of inorganic substances are fed to the modified cyanobacteria for culturing.
  • the protein can be obtained efficiently.
  • an enzyme for producing a raw material or a compound of a food component, a diagnostic enzyme or a therapeutic enzyme in the medical field, a feed enzyme in the agricultural, fishery and livestock field, and the like can be obtained.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PCT/JP2020/042549 2019-11-21 2020-11-16 改変シアノバクテリア、改変シアノバクテリアの製造方法、及び、タンパク質の製造方法 Ceased WO2021100640A1 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP20890876.4A EP4063483A4 (en) 2019-11-21 2020-11-16 MODIFIED CYANOBACTERIA, METHOD FOR PRODUCING MODIFIED CYANOBACTERIA AND METHOD FOR PRODUCING PROTEINS
CN202080078397.XA CN114651060A (zh) 2019-11-21 2020-11-16 修饰蓝细菌、修饰蓝细菌的制造方法以及蛋白的制造方法
JP2021558356A JP7766262B2 (ja) 2019-11-21 2020-11-16 分泌されたタンパク質の製造方法
US17/748,617 US20220325312A1 (en) 2019-11-21 2022-05-19 Modified cyanobacterium, modified cyanobacterium production method, and protein production method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019-210114 2019-11-21
JP2019210114 2019-11-21

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/748,617 Continuation US20220325312A1 (en) 2019-11-21 2022-05-19 Modified cyanobacterium, modified cyanobacterium production method, and protein production method

Publications (1)

Publication Number Publication Date
WO2021100640A1 true WO2021100640A1 (ja) 2021-05-27

Family

ID=75980740

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/042549 Ceased WO2021100640A1 (ja) 2019-11-21 2020-11-16 改変シアノバクテリア、改変シアノバクテリアの製造方法、及び、タンパク質の製造方法

Country Status (5)

Country Link
US (1) US20220325312A1 (https=)
EP (1) EP4063483A4 (https=)
JP (1) JP7766262B2 (https=)
CN (1) CN114651060A (https=)
WO (1) WO2021100640A1 (https=)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2022186216A1 (https=) * 2021-03-04 2022-09-09
EP4091453A4 (en) * 2019-12-23 2023-09-20 Panasonic Intellectual Property Management Co., Ltd. METHOD FOR PRODUCING A PLANT GROWTH PROMOTER, PLANT GROWTH PROMOTER AND METHOD FOR PROMOTING PLANT GROWTH
WO2023195367A1 (ja) 2022-04-08 2023-10-12 パナソニックＩｐマネジメント株式会社 シアノバクテリアの外膜剥離の判定方法、シアノバクテリアの外膜剥離の判定装置、及び、プログラム
WO2023233996A1 (ja) * 2022-05-31 2023-12-07 パナソニックＩｐマネジメント株式会社 改変プロモーター、発現ベクター、微生物、物質の生産方法、改変シアノバクテリア及び改変プロモーターの作製方法
WO2024024427A1 (ja) 2022-07-26 2024-02-01 パナソニックＩｐマネジメント株式会社 シアノバクテリアの外膜剥離の判定方法、シアノバクテリアの外膜剥離の判定装置、及び、プログラム
WO2025041758A1 (ja) * 2023-08-23 2025-02-27 パナソニックＩｐマネジメント株式会社 抗酸化剤、活性酸素の除去方法、及び抗酸化剤の製造方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2023248690A1 (https=) * 2022-06-20 2023-12-28

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6341676B2 (https=) 1983-02-03 1988-08-18 Mitsubishi Heavy Ind Ltd
JP2015109828A (ja) 2011-10-18 2015-06-18 国立大学法人茨城大学 自己溶菌能を有するシアノバクテリアを用いたバイオ燃料等有用物質の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2015368667A1 (en) * 2014-12-22 2017-07-13 Kao Corporation Modified cyanobacteria
EP4063485A4 (en) * 2019-11-21 2023-07-19 Panasonic Intellectual Property Management Co., Ltd. ELECTRON CARRIER, METHOD OF MAKING AN ELECTRON CARRIER AND METHOD OF ELECTRON TRANSFER
WO2021100642A1 (ja) * 2019-11-21 2021-05-27 パナソニックＩｐマネジメント株式会社 改変シアノバクテリア、改変シアノバクテリアの製造方法、及び、タンパク質の製造方法
CN114901830A (zh) * 2019-12-23 2022-08-12 松下知识产权经营株式会社 植物生长促进剂的制造方法、植物生长促进剂及植物生长促进方法
CN116600636A (zh) * 2020-12-25 2023-08-15 松下知识产权经营株式会社 植物酸性转化酶活化剂的制造方法、植物酸性转化酶活化剂及植物酸性转化酶活化方法
JP2022134906A (ja) * 2021-03-04 2022-09-15 パナソニックＩｐマネジメント株式会社 バイオフィルムの製造方法、バイオフィルム、及び有機物の製造方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6341676B2 (https=) 1983-02-03 1988-08-18 Mitsubishi Heavy Ind Ltd
JP2015109828A (ja) 2011-10-18 2015-06-18 国立大学法人茨城大学 自己溶菌能を有するシアノバクテリアを用いたバイオ燃料等有用物質の製造方法

Non-Patent Citations (14)

* Cited by examiner, † Cited by third party
Title
ANDREW H. NG ET AL.: "Fine-Tuning of Photoautotrophic Protein Production by Combining Promoters and Neutral Sites in the Cyanobacterium Synechocystis sp. Strain PCC 6803", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, vol. 81, 2015, pages 6857 - 6863
JASON DEXTERPENGCHENG FU: "Energy & Environmental Science", vol. 2, 2009, ROYAL SOCIETY OF CHEMISTRY, article "Metabolic engineering of cyanobacteria for ethanol production", pages: 857 - 864
JIE ZHOU ET AL.: "Discovery of a super-strong promoter enable efficient production of heterologous proteins in cyanobacteria", SCIENTIFIC REPORTS, NATURE RESEARCH, vol. 4, no. 4500, 2014
JURGENSWECKESSER, J. BACTERIOL., vol. 168, 1986, pages 568 - 573
KOJIMA ET AL., BIOSCI. BIOTECH. BIOCHEM., vol. 10, 2016, pages 1954 - 1959
KOJIMA ET AL., J. BIOL. CHEM., vol. 291, 2016, pages 20198 - 20209
KOJIMA SEIJI, MURAMOTO KOJI, KUSANO TOMONOBU: "Outer Membrane Proteins Derived from Non-cyanobacterial Lineage Cover the Peptidoglycan of Cyanophora paradoxa Cyanelles and Serve as a Cyanelle Diffusion Channel", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, vol. 291, no. 38, 29 June 2016 (2016-06-29), US, pages 20198 - 20209, XP055825633, ISSN: 0021-9258, DOI: 10.1074/jbc.M116.746131 *
KOJIMA SEIJI: "Elucidation and application of bacterial-derived membrane stabilization mechanism and substance permeation mechanism that function in the chloroplast surface membrane", 23 April 2018 (2018-04-23), pages 1 - 2, XP055921776, Retrieved from the Internet <URL:https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-18H02117> [retrieved on 20201214] *
KOWATA ET AL., J. BACTERIOL., vol. 199, 2017, pages e00371 - 17
KOWATA HIKARU: "Studies on molecular basis of cyanobacterial outer membrane function and its evolutionary relationship with primitive chloroplasts", THESIS, 27 March 2018 (2018-03-27), Tohoku University, XP055825637, Retrieved from the Internet <URL:http://hdl.handle.net/10097/00122689> [retrieved on 20201214] *
MESNAGE ET AL., EMBO J., vol. 19, 2000, pages 4473 - 4484
See also references of EP4063483A4
SHOTA ATSUMI ET AL.: "Nature Biotechnology", vol. 27, 2009, NATURE PUBLISHING GROUP, article "Direct photosynthetic recycling of carbon dioxide to isobutyraldehyde", pages: 1177 - 1180
YAO ET AL., ACS SYNTH. BIOL., vol. 5, 2016, pages 207 - 212

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4091453A4 (en) * 2019-12-23 2023-09-20 Panasonic Intellectual Property Management Co., Ltd. METHOD FOR PRODUCING A PLANT GROWTH PROMOTER, PLANT GROWTH PROMOTER AND METHOD FOR PROMOTING PLANT GROWTH
JP2024019520A (ja) * 2019-12-23 2024-02-09 パナソニックＩｐマネジメント株式会社 植物成長促進剤の製造方法、植物成長促進剤、及び、植物成長促進方法
JP7801672B2 (ja) 2019-12-23 2026-01-19 パナソニックＩｐマネジメント株式会社 植物成長促進剤の製造方法、植物成長促進剤、及び、植物成長促進方法
JPWO2022186216A1 (https=) * 2021-03-04 2022-09-09
WO2022186216A1 (ja) * 2021-03-04 2022-09-09 パナソニックＩｐマネジメント株式会社 改変シアノバクテリア、改変シアノバクテリアの製造方法、及び、タンパク質の製造方法
WO2023195367A1 (ja) 2022-04-08 2023-10-12 パナソニックＩｐマネジメント株式会社 シアノバクテリアの外膜剥離の判定方法、シアノバクテリアの外膜剥離の判定装置、及び、プログラム
WO2023233996A1 (ja) * 2022-05-31 2023-12-07 パナソニックＩｐマネジメント株式会社 改変プロモーター、発現ベクター、微生物、物質の生産方法、改変シアノバクテリア及び改変プロモーターの作製方法
WO2024024427A1 (ja) 2022-07-26 2024-02-01 パナソニックＩｐマネジメント株式会社 シアノバクテリアの外膜剥離の判定方法、シアノバクテリアの外膜剥離の判定装置、及び、プログラム
WO2025041758A1 (ja) * 2023-08-23 2025-02-27 パナソニックＩｐマネジメント株式会社 抗酸化剤、活性酸素の除去方法、及び抗酸化剤の製造方法

Also Published As

Publication number Publication date
EP4063483A1 (en) 2022-09-28
JP7766262B2 (ja) 2025-11-10
US20220325312A1 (en) 2022-10-13
EP4063483A4 (en) 2023-12-20
CN114651060A (zh) 2022-06-21
JPWO2021100640A1 (https=) 2021-05-27

Similar Documents

Publication Publication Date Title
JP7766262B2 (ja) 分泌されたタンパク質の製造方法
JP7450189B2 (ja) 植物成長促進剤の製造方法、植物成長促進剤、及び、植物成長促進方法
EP2726599B1 (en) Regulation of toxin and antitoxin genes for biological containment
US12528844B2 (en) Modified cyanobacterium, modified cyanobacterium production method, and protein production method
JPWO2021100640A5 (https=)
JP2022134906A (ja) バイオフィルムの製造方法、バイオフィルム、及び有機物の製造方法
Zedler et al. Self-assembly of nanofilaments in cyanobacteria for protein co-localization
CN107257851A (zh) 正面影响天然或工程化的真核细胞的生理学的细菌伴侣蛋白的组合
KR20140004219A (ko) 대장균에서 이형 단백질 생산을 위한 새로운 발현 및 분비 벡터 시스템
US20250147032A1 (en) Method for determining deprivation of outer membrane of cyanobacterium, apparatus for determining deprivation of outer membrane of cyanobacterium, and program
US20240084245A1 (en) Modified cyanobacterium, modified cyanobacterium production method, and protein production method
KR102911445B1 (ko) 오토라이신을 활용한 미세조류의 유전자 교정 효율을 증대시키기 위한 시스템 및 방법
JP2024045256A (ja) 農作物の栽培方法
US20250098687A1 (en) Plant disease resistance inducing agent, plant disease resistance inducing method, and method for producing plant disease resistance inducing agent
JP2022134907A (ja) バイオフィルムの製造方法、バイオフィルム、及び有機物の製造方法
JP2022102901A (ja) 植物高品質化剤の製造方法、植物高品質化剤、及び、植物高品質化方法
JP2024010288A (ja) 乾燥菌体の製造方法、及び、乾燥菌体
Nagakubo et al. Contractile injection systems facilitate sporogenic differentiation of bacteria through the action of a phage tapemeasure protein-related effector.
CN120504728B (zh) 一种多肽在抑制细菌或制备抑制细菌的试剂中的应用
JP2023182951A (ja) トマト果実の高糖度化方法、トマト果実の高糖度化剤及びその製造方法
WO2022186217A1 (ja) 植物成長促進剤の製造方法、植物成長促進剤、及び、植物成長促進方法
WO2023107014A1 (en) A method for increasing the permeability of outer cellular structures in vibrio natriegens from the aspect of extracellular transport of recombinant proteins
KR20220034576A (ko) 비-항생제 내성 선별 마커를 포함하는 선별 시스템
WO2019038789A1 (en) RECOMBINANT VECTOR COMPRISING FUSION DNA FOR CELL SURFACE DISPLAY AND USES THEREOF
Nies Transformation of the filamentous Cyanobacterium Phormidium lacuna Electroporation versus Natural Transformation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20890876

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021558356

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2020890876

Country of ref document: EP

Effective date: 20220621